Lilly(Eli) & Company
NYSE: LLY
$905.38
-$3.66 (-0.4%)
Closing Price on June 28, 2024
LLY Articles
Eli Lilly shares retreated after it released mixed third-quarter financial results before the markets opened on Wednesday.
Published:
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
Published:
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
Published:
The September 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Eli Lilly announced some good news for people suffering moderate to severe plaque psoriasis when it presented at the 5th Annual Maui Derm NP+PA Fall meeting.
Published:
These four top large-cap pharmaceutical stocks for investors to consider all pay solid dividends and look like very solid fourth-quarter ideas.
Published:
The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
The August 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
Published:
Eli Lilly shares dipped on Monday after the firm announced results from its midstage clinical trial for the treatment of lung cancer.
Published:
NextCure appears to be one of those companies that has flown under the radar of the investing community since its initial public offering in 2019.
Published:
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Eli Lilly shares made a handy gain on Tuesday after the firm announced results from its late-stage study for the treatment of moderate to severe plaque psoriasis.
Published:
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.
Published:
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
The July 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published: